questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Signes et symptômes digestifs
Hyperphagie
Hyperphagie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hyperphagie
Troubles de l'alimentation
Évaluation psychologique
Nutrition
Trouble de l'hyperphagie boulimique
DSM-5
Symptômes
5
Symptômes
Troubles de l'alimentation
Douleur abdominale
Hyperphagie
Diabète de type 2
Troubles métaboliques
Prévention
5
Éducation nutritionnelle
Gestion du stress
Soutien social
Troubles alimentaires
Sensibilisation
Prévention
Exercice physique
Comportements alimentaires
Méditation
Gestion du stress
Traitements
5
Thérapie comportementale
Médicaments
Thérapie cognitive
Comportement alimentaire
Soutien nutritionnel
Habitudes alimentaires
Hospitalisation
Traitement intensif
Complications
5
Maladies cardiovasculaires
Obésité
Reflux gastro-œsophagien
Douleurs abdominales
Troubles du sommeil
Inconfort physique
Facteurs de risque
5
Antécédents familiaux
Stress
Stress
Troubles alimentaires
Antécédents de troubles alimentaires
Hyperphagie
Isolement social
Comportements alimentaires
Changements hormonaux
Appétit
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperphagie : Questions médicales les plus fréquentes",
"headline": "Hyperphagie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperphagie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperphagie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Signes et symptômes digestifs",
"url": "https://questionsmedicales.fr/mesh/D012817",
"about": {
"@type": "MedicalCondition",
"name": "Signes et symptômes digestifs",
"code": {
"@type": "MedicalCode",
"code": "D012817",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Boulimie",
"alternateName": "Bulimia",
"url": "https://questionsmedicales.fr/mesh/D002032",
"about": {
"@type": "MedicalCondition",
"name": "Boulimie",
"code": {
"@type": "MedicalCode",
"code": "D002032",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.645.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperphagie",
"alternateName": "Hyperphagia",
"code": {
"@type": "MedicalCode",
"code": "D006963",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrea M Haqq",
"url": "https://questionsmedicales.fr/author/Andrea%20M%20Haqq",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, University of Alberta, 8440 - 112 St NW, Edmonton, AB, T6G 2B7, Canada. haqq@ualberta.ca."
}
},
{
"@type": "Person",
"name": "Arashdeep Singh",
"url": "https://questionsmedicales.fr/author/Arashdeep%20Singh",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA."
}
},
{
"@type": "Person",
"name": "Julia von Schnurbein",
"url": "https://questionsmedicales.fr/author/Julia%20von%20Schnurbein",
"affiliation": {
"@type": "Organization",
"name": "Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany."
}
},
{
"@type": "Person",
"name": "Martin Wabitsch",
"url": "https://questionsmedicales.fr/author/Martin%20Wabitsch",
"affiliation": {
"@type": "Organization",
"name": "Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany. Electronic address: Martin.Wabitsch@uniklinik-ulm.de."
}
},
{
"@type": "Person",
"name": "Usha G Mallya",
"url": "https://questionsmedicales.fr/author/Usha%20G%20Mallya",
"affiliation": {
"@type": "Organization",
"name": "Rhythm Pharmaceuticals, Inc., Boston, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists.",
"datePublished": "2022-05-26",
"url": "https://questionsmedicales.fr/article/35643416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cgh.2022.04.042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prognosis of naevoid melanomas.",
"datePublished": "2023-10-09",
"url": "https://questionsmedicales.fr/article/37832354",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2023.154881"
}
},
{
"@type": "ScholarlyArticle",
"name": "The direct prognosis comparison of",
"datePublished": "2023-06-02",
"url": "https://questionsmedicales.fr/article/37268989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40001-023-01140-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma.",
"datePublished": "2023-11-28",
"url": "https://questionsmedicales.fr/article/38017592",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40001-023-01534-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37208851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1346-8138.16840"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes digestifs",
"item": "https://questionsmedicales.fr/mesh/D012817"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hyperphagie",
"item": "https://questionsmedicales.fr/mesh/D006963"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperphagie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperphagie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperphagie",
"description": "Comment diagnostiquer l'hyperphagie ?\nQuels tests sont utilisés pour l'hyperphagie ?\nL'hyperphagie est-elle liée à d'autres troubles ?\nQuels critères DSM sont utilisés pour l'hyperphagie ?\nL'hyperphagie peut-elle être confondue avec d'autres troubles ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Prognosis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperphagie",
"description": "Quels sont les symptômes de l'hyperphagie ?\nL'hyperphagie provoque-t-elle des douleurs ?\nY a-t-il des signes psychologiques associés ?\nComment l'hyperphagie affecte-t-elle le poids ?\nL'hyperphagie peut-elle causer des troubles métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Prognosis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperphagie",
"description": "Comment prévenir l'hyperphagie ?\nLe soutien social aide-t-il à prévenir l'hyperphagie ?\nLes programmes de sensibilisation sont-ils efficaces ?\nL'exercice physique aide-t-il à prévenir l'hyperphagie ?\nLes techniques de relaxation sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Prognosis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperphagie",
"description": "Quels traitements sont disponibles pour l'hyperphagie ?\nLa thérapie cognitive est-elle efficace ?\nDes médicaments sont-ils prescrits pour l'hyperphagie ?\nLe soutien nutritionnel est-il important ?\nL'hyperphagie nécessite-t-elle une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Prognosis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperphagie",
"description": "Quelles complications peuvent survenir avec l'hyperphagie ?\nL'hyperphagie peut-elle affecter la santé mentale ?\nY a-t-il des risques de maladies cardiovasculaires ?\nDes problèmes digestifs peuvent-ils survenir ?\nL'hyperphagie peut-elle entraîner des troubles du sommeil ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Prognosis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperphagie",
"description": "Quels sont les facteurs de risque de l'hyperphagie ?\nLe stress est-il un facteur de risque ?\nLes antécédents de troubles alimentaires augmentent-ils le risque ?\nL'isolement social est-il un facteur de risque ?\nLes changements hormonaux influencent-ils l'hyperphagie ?",
"url": "https://questionsmedicales.fr/mesh/D006963?mesh_terms=Prognosis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperphagie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des habitudes alimentaires et des symptômes associés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hyperphagie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun test spécifique, mais des évaluations psychologiques et nutritionnelles peuvent être effectuées."
}
},
{
"@type": "Question",
"name": "L'hyperphagie est-elle liée à d'autres troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut coexister avec des troubles comme l'anxiété ou la dépression."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés pour l'hyperphagie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le DSM-5 définit des critères spécifiques pour le trouble de l'hyperphagie boulimique."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle être confondue avec d'autres troubles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la boulimie ou l'orthorexie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperphagie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une consommation excessive de nourriture, des sentiments de honte et de culpabilité."
}
},
{
"@type": "Question",
"name": "L'hyperphagie provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs abdominales dues à une suralimentation fréquente."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes psychologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme l'anxiété, la dépression et une faible estime de soi sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment l'hyperphagie affecte-t-elle le poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une prise de poids significative et des problèmes de santé associés."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle causer des troubles métaboliques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut contribuer à des troubles métaboliques comme le diabète de type 2."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperphagie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une éducation nutritionnelle et la gestion du stress."
}
},
{
"@type": "Question",
"name": "Le soutien social aide-t-il à prévenir l'hyperphagie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien social peut réduire le risque de développer des troubles alimentaires."
}
},
{
"@type": "Question",
"name": "Les programmes de sensibilisation sont-ils efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes de sensibilisation peuvent aider à identifier et à traiter les problèmes tôt."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir l'hyperphagie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer l'humeur et réduire les comportements alimentaires compulsifs."
}
},
{
"@type": "Question",
"name": "Les techniques de relaxation sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la méditation peuvent aider à gérer le stress et les envies alimentaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'hyperphagie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, la médication et le soutien nutritionnel."
}
},
{
"@type": "Question",
"name": "La thérapie cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie cognitive peut aider à modifier les comportements alimentaires et les pensées."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils prescrits pour l'hyperphagie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antidépresseurs et des médicaments anti-anxiété peuvent être prescrits pour aider."
}
},
{
"@type": "Question",
"name": "Le soutien nutritionnel est-il important ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un soutien nutritionnel aide à établir des habitudes alimentaires saines."
}
},
{
"@type": "Question",
"name": "L'hyperphagie nécessite-t-elle une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, une hospitalisation peut être nécessaire pour un traitement intensif."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hyperphagie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'obésité, le diabète, et des problèmes cardiovasculaires."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle affecter la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des troubles mentaux comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies cardiovasculaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperphagie augmente le risque de maladies cardiovasculaires en raison de l'obésité."
}
},
{
"@type": "Question",
"name": "Des problèmes digestifs peuvent-ils survenir ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes comme le reflux gastro-œsophagien et des douleurs abdominales peuvent se produire."
}
},
{
"@type": "Question",
"name": "L'hyperphagie peut-elle entraîner des troubles du sommeil ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des troubles du sommeil en raison de l'inconfort physique et psychologique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hyperphagie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et des événements stressants."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel peut déclencher des épisodes d'hyperphagie chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Les antécédents de troubles alimentaires augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de troubles alimentaires augmente le risque d'hyperphagie."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement social peut contribuer à des comportements alimentaires désordonnés."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux influencent-ils l'hyperphagie ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements hormonaux, comme ceux liés à la grossesse, peuvent affecter l'appétit."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Pediatrics, University of Alberta, 8440 - 112 St NW, Edmonton, AB, T6G 2B7, Canada. haqq@ualberta.ca.
Publications dans "Hyperphagie" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Rare Endocrine Diseases, Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany. Electronic address: Martin.Wabitsch@uniklinik-ulm.de.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Rhythm Pharmaceuticals, Inc., Boston, MA, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Hypothalamic Research, Departments of Internal Medicine and Neuroscience, Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Center for Hypothalamic Research, Departments of Internal Medicine and Neuroscience, Peter O'Donnell Jr. Brain Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Vanderbilt University Medical Center, Nashville, Tennessee.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Case Western Reserve University, Cleveland, Ohio.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
The John B. Pierce Laboratory, New Haven, CT, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA; The John B. Pierce Laboratory, New Haven, CT, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA; The John B. Pierce Laboratory, New Haven, CT, USA; Yale University, New Haven, CT, USA. Electronic address: gdelartigue@ufl.edu.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics University of Florida College of Medicine Gainesville Florida USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Foundation for Prader-Willi Research, Walnut, California, United States of America.
PWS-Clinical Trial Consortium, Walnut, California, United States of America.
Department of Genetics, University of Alabama, Birmingham, Alabama, United States of America.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Foundation for Prader-Willi Research, Walnut, California, United States of America.
PWS-Clinical Trial Consortium, Walnut, California, United States of America.
Department of Rehabilitation Medicine, University of Washington, Seattle, Washington, United States of America.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Sağlik Bilimleri University, Tepecik Training and Research Hospital, İzmir, Turkey.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Nutrition and Dietetics, Sağlik Bilimleri University, Tepecik Training and Research Hospital, İzmir, Turkey.
Publications dans "Hyperphagie" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Dokuz Eylül University, Faculty of Medicine, İzmir, Turkey.
Publications dans "Hyperphagie" :
Patients require a clear understanding of their prognosis to make informed decisions about their care. The aim of this study was to compare the perceptions of prognosis and transplant candidacy betwee...
Patients with cirrhosis and their hepatologists were prospectively recruited at an urban liver transplant center. Patients and hepatologists were asked about transplant candidacy and about how many ye...
Seventy patients and 6 hepatologists were enrolled in the study. Patients were predominantly male (61.4%) and white (68.6%), with a mean MELD-Na score of 19 ± 9. There was no-slight agreement between ...
Patients with cirrhosis are more optimistic and less accurate in their predictions of survival compared with hepatologists, although they are more realistic about their transplant candidacy. Aligning ...
There appear to be several variants of naevoid melanoma suspected as having different outcomes, but follow-up studies have been few. We aimed to assess the prognosis of naevoid melanomas in a multi-ce...
From histopathology records we ascertained patients in the UK, Australia and Italy diagnosed with maturing naevoid melanoma (n = 65; 14; 7 respectively) and nodular/papillomatous naevoid melanoma (12;...
Among UK patients, there was a non-significantly lower risk of melanoma death in maturing naevoid vs SSM, including after accounting for competing causes of death (SHR 0.40, 95% confidence interval (C...
There was no significant difference in risk of death from melanomas with naevoid features, and SSM. Nodular/ papillomatous naevoid melanoma patients did not carry higher risk of death than SSM patient...
This study aims to compare the clinical outcomes after performing radical prostatectomy (RP) or low-dose-rate brachytherapy (LDR) for patients with intermediate-risk prostate cancer (IRPC)....
We performed a retrospective analysis on 361 IRPC patients who underwent treatment in Peking Union Medical College Hospital from January 2014 to August 2021, of which 160 underwent RP and 201 underwen...
Median follow-up was 54 months for RP and 69 months for LDR. According to log-rank test, the differences of 5-year bRFS (70.2% vs 83.2%, P = 0.003) and 8-year bRFS (63.1% vs 68.9%, P < 0.001) between ...
LDR is a reasonable treatment option for IRPC patients, yielding improved bRFS and equivalent rates of cRFS, CSS and OS when compared with RP....
Tumor size plays an important role in the staging and treatment of thyroid carcinoma. A tumor with a maximum diameter of 1 cm or less is referred to as microcarcinoma. It is unclear if the clinicopath...
The patients with medullary thyroid carcinoma underwent radical operation at our hospital between December 2000 and January 2022 were retrospectively studied. A database was established for this study...
A total of 198 patients were included. Of them, 56 and 142 with MTMC and macrocarcinoma, respectively. Few patients in the MTMC group had lateral lymph node metastasis. One hundred and seventy-eight (...
Patients with MTMC have a lower risk of lateral lymph node metastasis and better disease-free survival than those with macrocarcinoma. However, there was no significant difference in the overall survi...
Alopecia totalis (AT) and alopecia universalis (AU) is known to have a poor prognosis with high relapse rate, and treatment failure is observed in most patients, regardless of the type of therapy. Alt...
Immune and stromal cells contribute to glioma progression by infiltrating the tumor microenvironment. We used clinical characteristics, RNA sequencing data and the ESTIMATE algorithm to obtain stromal...
Prognostic studies are investigations to estimate the risk or probability of future outcomes in people with established disease. Ideally based on cohort studies where it is established: the time of on...
Cholangiocarcinoma (CHOL) is a malignant tumor that originates in the extrahepatic bile duct and can extend from the hilar region to the lower end of the common bile duct. The prognosis of CHOL patien...
The TCGA-CHOL dataset was applied to obtain and analyze the coexpression of 1281 m...
Kaplan-Meier analysis indicated poor overall survival (OS) for the high-risk group. Two Gene Expression Omnibus (GEO) datasets (GSE89748 and GSE107943) were used to validate the risk model. The result...
Our findings suggest that this model can be a prognostic indicator for CHOL patients....
Head and neck squamous cell carcinoma (HNSCC), the most common head and neck cancer, is highly aggressive and heterogeneous, resulting in variable prognoses and immunotherapeutic outcomes. Natural kil...
In this study, NRGs were used to classify HNSCC from the TCGA-HNSCC and GEO cohorts. The genes were evaluated using univariate cox regression analysis based on the differential analysis of normal and ...
With the TCGA-HNSCC data, we established a nomogram based on the 17-NRGs signature and a variety of clinicopathological characteristics. The low-risk group exhibited a better effect when it came to im...
17-NRGs signature and nomograms demonstrate excellent predictive performance and offer new perspectives for assessing pre-immune efficacy, which will facilitate future precision immuno-oncology resear...
Genetics plays a significant role in determining an individual's susceptibility to dental diseases, the response to dental treatments, and the overall prognosis of dental interventions. Here, the auth...